Bloomberg

France Won’t Delay Second Covid Vaccine Dose, Citing Risks From New Variants

France decided not to delay second doses of the Covid-19 vaccine from Pfizer Inc. and BioNTech SE, shunning the advice of its health authority and citing risks and uncertainties in the face of new variants.

Continue

About the author

Angela

Leave a Comment